Cancer, Hematological Tumors, and Immuno-Oncology Solutions

Unlocking the essence of disease through cellular intelligence to drive precision medicine and health management

Integrating multi-dimensional cell analysis with AI technology, we provide in-depth insights into the tumor microenvironment, immune status, and hematological diseases, facilitating precise diagnosis, treatment response prediction, and the development of personalized treatment strategies.

Clinical Challenges

Clinical Challenges

Significant variation in treatment response

Patients respond differently to chemotherapy, targeted therapy, and immunotherapy, requiring more precise biomarker support.

High tumor heterogeneity

Even among patients with the same cancer type, there can be significant differences in their genetic characteristics, immune status, and treatment response.

High demand for disease and recurrence monitoring

Following cancer treatment, long-term monitoring of disease changes and recurrence risk remains essential to guide subsequent treatment decisions.

Complex tumor immune microenvironment

The interaction between tumor cells and immune cells affects disease progression and the efficacy of immunotherapy.

Key Assessment Areas

Key Assessment Areas

B Cell and Hematological Malignancy Analysis

B Cell and Hematological Malignancy Analysis

Analyze B cell subsets, surface markers, immunoglobulin light chains, and monoclonal immunoglobulins to assist in the precise typing and diagnosis of hematological malignancies and B cell diseases.

Tumor Microenvironment Assessment

Tumor Microenvironment Assessment

Integrate TAMs, MDSCs, CAFs, cytokines, and immune infiltration analysis to elucidate the tumor microenvironment and immune escape mechanisms.

Inflammatory Response Analysis

Inflammatory Response Analysis

Through comprehensive monitoring of inflammation and damage markers, accurately identify the body's health risks, from acute warning signs to long-term chronic conditions.

Cell and Biomarker Analysis

Biomarker Analysis

Tumor Microenvironment Analysis

  • Tumor-associated macrophages
  • Myeloid-derived suppressor cells
  • Cancer-associated fibroblasts
  • Cytokines
  • Immune cell infiltration
  • Stromal cells

Tumor Immune Analysis

  • TIL (Tumor-infiltrating lymphocytes)
  • Treg (Regulatory T cells)
  • PD-1 / PD-L1 immune checkpoint
  • Immune activation state
  • Tumor immune escape mechanism

Tumor Biomarker Analysis

  • Immunotherapy Response Prediction
  • Targeted Therapy Selection
  • Disease Monitoring

Testing Workflow

Workflow

  1. Sample Collection

    Sample Collection

  2. Sample Processing and Separation

    Sample Processing and Separation

  3. Flow Cytometry Testing

    Flow Cytometry Testing

  4. AI Smart Analysis

    AI Smart Analysis

  5. AI Cell Report

    AI Cell Report

  6. Clinical Decision Support

    Clinical Decision Support

Clinical Applications

Clinical Applications

Precise diagnosis and root cause analysis

Precise diagnosis and root cause analysis

Identify the true cause behind your symptoms through a comprehensive assessment.

Health Risk Assessment

Health Risk Assessment

Early detection of health risks, prevention of chronic diseases

Disease Progression Prediction

Disease Progression Prediction

Predict disease trends and develop personalized management strategies.

Drug Development and Efficacy Evaluation

Drug Development and Efficacy Evaluation

Evaluate the effects of drugs on nerve cells and immune cells.

Building the Future of Precision Medicine Together

Driving innovation with cellular intelligence to enhance the lives of more patients with cancer and blood disorders.